Results 201 to 210 of about 50,711 (215)

Autoimmune Hemolytic Anemias

2009
Publisher Summary This chapter reviews autoimmune hemolytic anemias (AIHA) which includes a group of disorders where autoantibodies are directed against red blood cell (RBC) membrane antigens. This results in shortened RBC survival through activation of the complement system and removal within the reticuloendothelial system.
Christopher D. Hillyer, Beth H. Shaz
openaire   +2 more sources

Autoimmune Hemolytic Anemia

Archives of Internal Medicine, 1977
Autoimmune hemolytic anemia (AHA) may be either primary (ie, "idiopathic," one third of all patients) or secondary (ie, associated with underlying illness, two thirds of all patients). A positive Coombs antiglobulin test is the most important criterion for diagnosis of AHA, and characterization of RBC coating (as to whether it is by IgG alone, by IgG ...
Hugh Chaplin, Louis V. Avioli
openaire   +3 more sources

Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review

European Journal of Haematology, 2018
Immune checkpoint inhibitors (CPI) are widely used in modern oncology and have improved the prognosis of lung cancer, malignant melanoma, and other malignancies.
Georges E. Tanios, Peter B. Doley, R. Munker   +2 more
semanticscholar   +1 more source

Warm Autoimmune Hemolytic Anemia

Hematology/Oncology Clinics of North America, 2015
Warm autoimmune hemolytic anemia (AIHA) is defined as the destruction of circulating red blood cells (RBCs) in the setting of anti-RBC autoantibodies that optimally react at 37°C. The pathophysiology of disease involves phagocytosis of autoantibody-coated RBCs in the spleen and complement-mediated hemolysis.
openaire   +2 more sources

Autoimmune Hemolytic Anemia in a Dog

Journal of the American Veterinary Medical Association, 1973
SUMMARY Autoimmune hemolytic anemia (aha) occurred in a 3½-year-old Cocker Spaniel. The clinical signs and blood values on initial examination were consistent with a diagnosis of aha; however, the results of Coombs’ antiglobulin test were not conclusive until 7 months later.
M D, Avolt, J E, Lund, J C, Pickett
openaire   +2 more sources

Immunotherapy-associated Autoimmune Hemolytic Anemia.

Hematology/Oncology Clinics of North America, 2022
Steven R Hwang, Antoine N. Saliba, A. Wolanskyj-Spinner   +2 more
semanticscholar   +1 more source

Autoimmune hemolytic anemia

Autoimmune hemolytic anemia (AIHA) encompasses a group of diseases mostly mediated by autoantibodies against erythrocyte surface antigens. This chapter will address the individual subtypes of AIHA with respect to epidemiology, pathogenesis, diagnostic procedure, clinical features, and therapy.
Berentsen, S, Frederiksen, Henrik, Fattizzo, Bruno   +2 more
openaire   +2 more sources

Autoimmune Hemolytic Anemia: A Review

American Journal of Clinical Pathology, 1971
Autoimmune hemolytic anemia (AIHA) represents the most elegant model of autoimmunity in humans. It is frequently associated with other diseases of altered immune states. By definition, antibody must be demonstrable in every case. Two types of antibody, cold and warm, are recognized.
openaire   +3 more sources

Treatment of autoimmune hemolytic anemias

Current Opinion in Hematology, 2001
Treatment of autoimmune hemolytic anemias varies depending on whether the patient has autoimmune hemolytic anemia of warm antibody type, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, or autoimmune hemolytic anemia secondary to an underlying disorder.
openaire   +3 more sources

Daratumumab for refractory warm autoimmune hemolytic anemia

Annals of Hematology, 2020
Ankur Jain, D. Gupta
semanticscholar   +1 more source